Comparison of Transfection Conditions for a Lentivirus Vector Produced in Large Volumes
- 20 September 2003
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 14 (14) , 1287-1296
- https://doi.org/10.1089/104303403322319372
Abstract
A number of different transfection reagents have been used for lentiviral vector production. We directly compared transfection buffers, DNA purification methods, chemical facilitators, and DNA concentrations to optimize production. The use of N,N-bis (2-hydroxyethyl)-2-aminoethanesulfonic acid (BES), sodium butyrate, and one fourth the total amount of DNA used in standard transient transfection protocols were the best conditions for virus production. These reagents were combined into a single protocol and scaled-up to produce liter quantities of virus in a multitray tissue culture vessel.Keywords
This publication has 52 references indexed in Scilit:
- Transfection of embryonal carcinoma cells at high efficiency using liposome‐mediated transfectionMolecular Reproduction and Development, 2002
- Targeted Transduction Patterns in the Mouse Brain by Lentivirus Vectors Pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV Envelope ProteinsMolecular Therapy, 2002
- Production and Neurotropism of Lentivirus Vectors Pseudotyped with Lyssavirus Envelope GlycoproteinsMolecular Therapy, 2001
- The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brainNature Biotechnology, 2001
- Sequences in the Cytoplasmic Tail of the Gibbon Ape Leukemia Virus Envelope Protein That Prevent Its Incorporation into Lentivirus VectorsJournal of Virology, 2001
- A Stable System for the High-Titer Production of Multiply Attenuated Lentiviral VectorsMolecular Therapy, 2000
- Lentiviral Vectors: Regulated Gene ExpressionMolecular Therapy, 2000
- Gene transfer in astrocytes: Comparison between different delivering methods and expression of the HIV-1 protein NefJournal of Neuroscience Research, 1999
- Optimized conditions for the production of recombinant amphotropic retroviral vector preparationsGene Therapy, 1997
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996